Mass Tort Advertising Campaign
Misdiagnosed Stroke Marketing & Claimant Acquisition
Misdiagnosed stroke claims sit at the top of the medical malpractice value pyramid: a patient arrives at an emergency department with stroke symptoms, is sent home with a diagnosis of vertigo, migraine, anxiety, or intoxication — and the window for clot-busting treatment closes. What follows is often permanent, catastrophic disability that timely diagnosis could have prevented, and that gap between the outcome that happened and the outcome that was available is the case.
For plaintiff firms, these are among the most valuable single-plaintiff cases in American law, and the fact pattern is tragically consistent enough to advertise for with precision.
Misdiagnosed Stroke at a glance
- Manufacturer(s)
- Hospitals / Emergency Providers
- Associated injuries
- Missed or Delayed Stroke Diagnosis
- Litigation status
- ACTIVE
- Campaign intake
- Open
The litigation landscape
The recurring clinical failure is well documented: posterior-circulation strokes and strokes in younger patients present with dizziness, headache, and nausea rather than the classic face-arm-speech triad — and emergency providers anchor on benign explanations. Time-sensitive interventions like thrombolysis and thrombectomy have defined treatment windows, so hours of delay convert a treatable event into lifelong impairment. Liability theories center on failure to perform stroke workups, premature discharge, and failure to escalate to imaging or neurology.
Because damages include lifetime care, lost earning capacity, and profound loss of quality of life, these cases support the substantial expert investment stroke litigation requires.
Who a campaign targets
Screening criteria firms typically apply in misdiagnosed stroke matters include:
- Presentation to an ER, urgent care, or physician with stroke-consistent symptoms that were attributed to another cause
- A stroke confirmed after discharge or delayed workup, with the delay documented in the records
- Serious permanent deficit — paralysis, cognitive impairment, speech loss, or death
- Care within the state's malpractice limitations period, and evidence timely treatment was plausible had the diagnosis been made
How MTAA runs Misdiagnosed Stroke campaigns
Stroke misdiagnosis creative works because survivors and families instantly recognize the story: sent home from the ER, told it was vertigo, the stroke confirmed days later. Scenario-led advertising surfaces exactly these households, and Meta reaches the caregiver networks who are often the ones searching. Screening is built to establish the two facts that matter within the first minutes: symptoms presented and diagnosis delayed.
MTAA runs stroke campaigns with the strict qualification discipline med mal demands, so counsel reviews only cases with real records behind them.
Pricing
Mass Tort Ad Agency runs Misdiagnosed Stroke campaigns on the same transparent model as every tort: actual Meta ad spend at cost plus a flat 15% management fee, a one-time $1,000 setup fee per tort, and $100 per signed retainer for CloudIntake qualification. No per-case markups, no lead resale, and the firm owns its ad account, pixel, creative, and claimant data.
Misdiagnosed Stroke advertising — common questions
Why are misdiagnosed stroke cases so valuable?
What is the most common fact pattern?
What must screening establish?
Does this run alongside mass tort campaigns?
Ready to run Misdiagnosed Stroke campaigns?
We build, run, and qualify Misdiagnosed Stroke claimant-acquisition campaigns end to end. Book a call and we'll walk you through the creative, audience, and intake plan.
Book a strategy call